Ken O'Flynn

1160. Deputy Ken O'Flynn asked the Minister for Health whether any publicly funded health-sector bodies classified by the Central Statistics Office as public bodies are legally independent companies limited by guarantee; the number identified; and the aggregate level of State funding provided to such bodies in each year since 2020. [38922/26]

1161. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted any governance risk assessment regarding publicly funded bodies that are legally independent of the State but depend primarily on Exchequer funding; and if so, to provide details. [38923/26]

1162. Deputy Ken O'Flynn asked the Minister for Health which specific body or office holds ultimate responsibility for approving, setting, reviewing, and enforcing national ambulance dispatch standards in Ireland. [38924/26]

1163. Deputy Ken O'Flynn asked the Minister for Health whether the Priority Dispatch Standard published by the Pre-Hospital Emergency Care Council contains defined maximum permissible time thresholds for emergency call handling, triage, dispatch allocation, or mobilisation; and if so, to provide details. [38925/26]

1164. Deputy Ken O'Flynn asked the Minister for Health whether the September 2025 review of the Priority Dispatch Standard identified any recommendations, deficiencies, operational concerns, governance gaps, or patient safety risks relating to ambulance dispatch practices; and if so, to provide details. [38926/26]

1165. Deputy Ken O'Flynn asked the Minister for Health whether any formal audit, external review, internal review, incident analysis, or governance assessment of ambulance dispatch delays has been conducted by the HSE, National Ambulance Service, HIQA, PHECC, or any external body since 2020; and if so, to provide details, including dates and findings. [38927/26]

1166. Deputy Ken O'Flynn asked the Minister for Health whether the absence of defined national maximum ambulance dispatch-time thresholds has been recorded on any HSE, National Ambulance Service, Department of Health, or associated risk register since 2020; and if so, to provide the risk category, current status, and mitigation measures. [38928/26]

1193. Deputy Ken O'Flynn asked the Minister for Health the number of patients removed from orthopaedic outpatient waiting lists through administrative validation in 2025, broken down by hospital, waiting-time band and reason for removal. [39036/26]

1194. Deputy Ken O'Flynn asked the Minister for Health the number of patients removed from orthopaedic inpatient or day-case waiting lists through administrative validation in 2025, broken down by hospital, waiting-time band and reason for removal. [39037/26]

1195. Deputy Ken O'Flynn asked the Minister for Health if an audit will be carried out to establish how many orthopaedic patients removed through administrative validation in 2025 were later re-presented or were re-referred for the same condition. [39038/26]

1196. Deputy Ken O'Flynn asked the Minister for Health if the HSE or NTPF records the full waiting time from GP referral to completed orthopaedic procedure; and if not, if the absence of full-pathway waiting-time data has been assessed as a governance risk. [39039/26]

1197. Deputy Ken O'Flynn asked the Minister for Health if the HSE records the number of patients awaiting orthopaedic outpatient assessment for knee replacement, who are not yet counted on an inpatient or day-case surgical waiting list. [39040/26]

1198. Deputy Ken O'Flynn asked the Minister for Health if any national clinical prioritisation framework exists for patients awaiting knee replacement who are experiencing severe pain, loss of mobility, inability to work or loss of independent living capacity. [39041/26]

1199. Deputy Ken O'Flynn asked the Minister for Health if the Waiting Time Action Plan 2026 includes specific targets for reducing orthopaedic outpatient waiting times; and if so, to provide those targets by HSE region. [39042/26]

1200. Deputy Ken O'Flynn asked the Minister for Health if the Waiting Time Action Plan 2026 includes specifically funded capacity for knee replacement pathways, including outpatient assessment, diagnostics, theatre capacity and post-operative rehabilitation. [39043/26]

1201. Deputy Ken O'Flynn asked the Minister for Health if patients awaiting orthopaedic care receive written confirmation to distinguish that they are on an outpatient assessment list or an inpatient/day-case surgical list. [39044/26]

1202. Deputy Ken O'Flynn asked the Minister for Health if her Department will examine the separate publication of outpatient and inpatient waiting lists, which understate the real waiting time experienced by patients requiring knee replacement surgery. [39045/26]

1203. Deputy Ken O'Flynn asked the Minister for Health the number of confirmed lyme disease cases recorded annually in the State from 2020 to 2026, in tabular form; and if she will make a statement on the matter. [39047/26]

1204. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains national clinical guidance for the diagnosis and treatment of lyme disease; if so, when such guidance was last reviewed or updated; and if she will make a statement on the matter. [39048/26]

1205. Deputy Ken O'Flynn asked the Minister for Health the extent general practitioners receive specific training or continuing professional development guidance relating to lyme disease diagnosis, treatment pathways and long-term complications; and if she will make a statement on the matter. [39049/26]

1206. Deputy Ken O'Flynn asked the Minister for Health if her Department or HSE has conducted a review of delayed diagnosis of lyme disease and associated patient outcomes; and if she will make a statement on the matter. [39050/26]

1207. Deputy Ken O'Flynn asked the Minister for Health the number of patients referred annually for specialist assessment relating to neurological complications associated with lyme disease from 2020 to 2026 [39051/26]

1208. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains a dedicated referral pathway for patients presenting with suspected neurological lyme disease, lyme arthritis or lyme carditis [39052/26]

1209. Deputy Ken O'Flynn asked the Minister for Health the laboratories recognised by the HSE for lyme disease testing; the testing methodologies currently utilised; and if a review of international testing standards has been undertaken since 2020. [39053/26]

1210. Deputy Ken O'Flynn asked the Minister for Health if the Department or HSE has examined international approaches to lyme disease diagnosis, testing and long-term patient management; if so, which jurisdictions were examined; and if she will make a statement on the matter. [39054/26]